866-997-4948(US-Canada Toll Free)

Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018

Published By :

GlobalData

Published Date : Aug 2012

Category :

Surgical Equipment

No. of Pages : 79 Pages


GlobalDatas new report, Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global brachytherapy devices market. The report provides market landscape, competitive landscape and market trends information on the brachytherapy devices market, as well as comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. It also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, Australia, India, China and Brazil.
  • Key categories covered include Temporary Brachytherapy Devices and Permanent Brachytherapy Devices.
  • Annualized market revenues data for 2011, forecast forward for seven years to 2018. Company shares data for 2011. 
  • Qualitative analysis of key market trends, market drivers, and restraints for the brachytherapy devices market
  • Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies
  • Key players covered include Oncura, CR Bard, Nucletron, Theragenics, IBt Bebig and Palomar Varian Medical Systems.

Reasons to buy

  • Develop business strategies by understanding the trends and developments that are driving the brachytherapy devices market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Whats the next big thing in the brachytherapy devices market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global brachytherapy devices market and the factors shaping it.
Table of Contents

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6

2 Introduction 7
2.1 GlobalData Report Guidance 7

3 Disease Overview 8
3.1 Breast Cancer 8
3.2 Signs and Symptoms 8
3.3 Epidemiology 8
3.4 Prostate Cancer 10
3.5 Signs and Symptoms 10
3.6 Epidemiology 11

4 Brachytherapy - Device Overview 13
4.1 Brachytherapy, Market Segmentation 14
4.1.1 Temporary Brachytherapy 14
4.1.2 Permanent Brachytherapy 15

5 Brachytherapy Devices - Global Market Characterization 16
5.1 Brachytherapy Devices Market, Global, Revenue ($m), Historic, 20042011 16
5.2 Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 20112018 17
5.3 Brachytherapy Devices Market, Key Trends 18
5.3.1 Multiple Imaging Techniques and High-precision Targeted Brachytherapy Play a Major Role in Deciding Brachytherapy Treatment Planning 18
5.3.2 New Radioisotopes for Increased Effectiveness Constantly Explored for Delivering Brachytherapy 19
5.4 Brachytherapy Devices, Market Dynamics 20
5.4.1 Market Drivers 21
5.4.2 Market Restraints 25

6 Brachytherapy Devices Market, Global, Segment Analysis, Revenue ($m), 20042018 27
6.1 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Historic, 20042011 27
6.2 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 20112018 28
6.3 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Historic, 20042011 29
6.4 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 20112018 30

7 Brachytherapy Devices Market, by Country, Revenue ($m), 20042018 31
7.1 Brachytherapy Devices Market, The US, Revenue ($m), Historic, 20042011 31
7.2 Brachytherapy Devices Market, The US, Revenue ($m), Forecast, 20112018 32
7.3 Brachytherapy Devices Market, The UK, Revenue ($m), Historic, 20042011 33
7.4 Brachytherapy Devices Market, The UK, Revenue ($m), Forecast, 20112018 34
7.5 Brachytherapy Devices Market, Germany, Revenue ($m), Historic, 20042011 35
7.6 Brachytherapy Devices Market, Germany, Revenue ($m), Forecast, 20112018 36
7.7 Brachytherapy Devices Market, France, Revenue ($m), Historic, 20042011 37
7.8 Brachytherapy Devices Market, France, Revenue ($m), Forecast, 20112018 38
7.9 Brachytherapy Devices Market, Italy, Revenue ($m), Historic, 20042011 39
7.10 Brachytherapy Devices Market, Italy, Revenue ($m), Forecast, 20112018 40
7.11 Brachytherapy Devices Market, Spain, Revenue ($m), Historic, 20042011 41
7.12 Brachytherapy Devices Market, Spain, Revenue ($m), Forecast, 20112018 42
7.13 Brachytherapy Devices Market, Japan, Revenue ($m), Historic, 20042011 43
7.14 Brachytherapy Devices Market, Japan, Revenue ($m), Forecast, 20112018 44

8 Brachytherapy Devices Market: Company Shares (%), 2011 45
8.1 Brachytherapy Devices Market, Global, Company Share (%), 2011 45
8.2 Temporary Brachytherapy Devices Market, Global, Company Share (%), 2011 47
8.3 Permanent Brachytherapy Devices Market, Global, Company Share (%), 2011 48
8.4 Brachytherapy Devices Market, Global, Competitive Assessment, 2011 50
8.5 Brachytherapy Devices Market, Key Market Participants 51
8.5.1 Oncura 51
8.5.2 C.R. Bard 53
8.5.3 Nucletron (an Elekta Company) 55
8.5.4 Theragenics 58
8.5.5 IBt Bebig 60
8.5.6 Varian Medical Systems, Inc. 62

9 Brachytherapy Devices Market, Deals Landscape 66
9.1 Brachytherapy Devices Market, Key Acquisitions, 20082012 67
9.1.1 Elekta Completes Acquisition of Nucletron for $523m 67
9.1.2 Eckert & Ziegler Subsidiary IBt Bebig Acquires SonoTECH GmbH 67
9.1.3 C. R. Bard Completes Acquisition of SenoRx for $213m 68
9.1.4 Huiheng Medical Completes Acquisition of Portola Medical 68
9.1.5 iCAD Completes Acquisition of Xoft 68
9.2 Brachytherapy Devices Market: Partnerships 69
9.3 Brachytherapy Devices Market: Key Partnerships, 20082012 70
9.3.1 Integrated Oncology Network Announced Partnership and has Acquired Equity Interests in Prologics and Northern Ohio Regional Cancer Center 70
9.3.2 IBA Dosimetry Enters into Distribution Agreement with Axios Oncology 71
9.3.3 Theragenics Signs Distribution Agreement with Oncura 71
9.3.4 Nucletron Enters into Licensing Agreement with MedCom and Pi-Medical 71
9.3.5 IsoRay Enters into Exclusive Licensing Agreement with Hologic 71
9.3.6 Theragenics Signs an Agreement with Core Oncology 72

10 Appendix 73
10.1 Market Definitions 73
10.1.1 Brachytherapy Devices 73
10.1.2 Permanent Brachytherapy Devices 73
10.1.3 Temporary Brachytherapy Devices 74
10.2 Acronyms 74
10.3 Sources 76
10.4 Research Methodology 77
10.4.1 Secondary Research 77
10.4.2 Primary Research 77
10.4.3 Models 78
10.4.4 Forecasts 78
10.4.5 Expert Panels 78
10.4.6 GlobalData Consulting 78
10.5 Contact Us 79
10.6 Disclaimer 79

List of Table


Table 1: Breast Cancer, Disease Population by Country, 2006-2011 9
Table 2: Prostate Cancer, Disease Population by Country, 2006-2011 11
Table 3: Brachytherapy Classification, 2012 14
Table 4: Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 16
Table 5: Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 17
Table 6: Physical Properties of New Brachytherapy Sources under Investigation 19
Table 7: Estimated Number of New Cancer Patients per 100,000 Population (All Ages), 2008-2020 21
Table 8: Cumulative Mean Prostate Cancer Treatment Costs over Five and Half Years, by Primary Treatment and Risk Factor 22
Table 9: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 27
Table 10: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 28
Table 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2004-2011 29
Table 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2011-2018 30
Table 13: Brachytherapy Devices Market, The US, Revenue ($m), 2004-2011 31
Table 14: Brachytherapy Devices Market, The US, Revenue ($m), 2011-2018 32
Table 15: Brachytherapy Devices Market, The UK, Revenue ($m), 2004-2011 33
Table 16: Brachytherapy Devices Market, The UK, Revenue ($m), 2011-2018 34
Table 17: Brachytherapy Devices Market, Germany, Revenue ($m), 2004-2011 35
Table 18: Brachytherapy Devices Market, Germany, Revenue ($m), 2011-2018 36
Table 19: Brachytherapy Devices Market, France, Revenue ($m), 2004-2011 37
Table 20: Brachytherapy Devices Market, France, Revenue ($m), 2011-2018 38
Table 21: Brachytherapy Devices Market, Italy, Revenue ($m), 2004-2011 39
Table 22: Brachytherapy Devices Market, Italy, Revenue ($m), 2011-2018 40
Table 23: Brachytherapy Devices Market, Spain, Revenue ($m), 2004-2011 41
Table 24: Brachytherapy Devices Market, Spain, Revenue ($m), 2011-2018 42
Table 25: Brachytherapy Devices Market, Japan, Revenue ($m), 2004-2011 43
Table 26: Brachytherapy Devices Market, Japan, Revenue ($m), 2011-2018 44
Table 27: Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 45
Table 28: Temporary Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 47
Table 29: Permanent Brachytherapy Devices Market, Global, Company Revenue ($m), 2011 48
Table 30: Oncura, Key Marketed Products, 2011 51
Table 31: C. R. Bard Inc., Key Marketed Products, 2011 53
Table 32: Nucletron, Brachytherapy, Key Marketed Products, 2011 56
Table 33: Theragenics Corporation, Brachytherapy, Key Marketed Products, 2011 58
Table 34: IBt Bebig, Key Marketed Products, 2011 60
Table 35: Varian Medical Systems, Inc, Key Marketed Products, 2011 62
Table 36: Brachytherapy Devices Market, Mergers and Acquisitions, Global, 2008-2012* 66
Table 37: Brachytherapy Devices Market, Partnerships, Global, 2008-2012* 69

List of Chart


Figure 1: Breast Cancer, Disease Population by Country, 20062011 9
Figure 2: Prostate Cancer, Disease Population by Country, 20062011 11
Figure 3: Brachytherapy Devices Market, Segmentation, 2012 14
Figure 4: Brachytherapy Devices Market, Global, Revenue ($m), 20042011 16
Figure 5: Brachytherapy Devices Market, Global, Revenue ($m), 20112018 17
Figure 6: Brachytherapy Devices, Market Dynamics 20
Figure 7: Estimated Number of New Cancer Patients per 100,000 Population (All Ages), 20082020 21
Figure 8: Use of Brachytherapy in Cancer Treatment, 2010 23
Figure 9: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 20042011 27
Figure 10: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 20112018 28
Figure 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 20042011 29
Figure 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 20112018 30
Figure 13: Brachytherapy Devices Market, The US, Revenue ($m), 20042011 31
Figure 14: Brachytherapy Devices Market, The US, Revenue ($m), 20112018 32
Figure 15: Brachytherapy Devices Market, The UK, Revenue ($m), 20042011 33
Figure 16: Brachytherapy Devices Market, The UK, Revenue ($m), 20112018 34
Figure 17: Brachytherapy Devices Market, Germany, Revenue ($m), 20042011 35
Figure 18: Brachytherapy Devices Market, Germany, Revenue ($m), 20112018 36
Figure 19: Brachytherapy Devices Market, France, Revenue ($m), 20042011 37
Figure 20: Brachytherapy Devices Market, France, Revenue ($m), 20112018 38
Figure 21: Brachytherapy Devices Market, Italy, Revenue ($m), 20042011 39
Figure 22: Brachytherapy Devices Market, Italy, Revenue ($m), 20112018 40
Figure 23: Brachytherapy Devices Market, Spain, Revenue ($m), 20042011 41
Figure 24: Brachytherapy Devices Market, Spain, Revenue ($m), 20112018 42
Figure 25: Brachytherapy Devices Market, Japan, Revenue ($m), 20042011 43
Figure 26: Brachytherapy Devices Market, Japan, Revenue ($m), 20112018 44
Figure 27: Brachytherapy Devices Market, Global, Company Share (%), 2011 45
Figure 28: Temporary Brachytherapy Devices Market, Global, Company Share (%), 2011 47
Figure 29: Permanent Brachytherapy Devices Market, Global, Company Share (%), 2011 48
Figure 30: Brachytherapy Devices Market, Global, Competitive Assessment, 2011 50
Figure 31: Oncura, SWOT Analysis, 2012 51
Figure 32: C.R. Bard, SWOT Analysis, 2012 54
Figure 33: Nucletron, SWOT Analysis, 2012 56
Figure 34: Nucletron, Product Launches, 2007-2012 57
Figure 35: Theragenics, SWOT Analysis, 2012 59
Figure 36: IBt Bebig, SWOT Analysis, 2012 61
Figure 37: Varian Medical Systems, Inc, SWOT Analysis, 2012 63
Figure 38: Varian, Product Launches, 2007-2012 64

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *